跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVA-LOSARTAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRIVA-LOSARTAN
Authorized
STANDARD
PRIVA-LOSARTAN
pharmapar inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4900d9c43659aa23
Company
pharmapar inc
Type
Standard
Approval Details
Approval Id
4900d9c43659aa23
Drug Approval Canada Name
PRIVA-LOSARTAN
Product Name
PRIVA-LOSARTAN
Status
Cancelled Post Market
Status Date
2021-07-08
Original Market Date
2016-05-09
Din
02446707
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.08
Atc Original
C09CA01 LOSARTAN
Atc Name
c 09 ca 01
Aig Number
0127971003
Company Name
pharmapar inc
Company Address
1565 Boul Lionel-Boulet, Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
LOSARTAN POTASSIUM
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4900d9c43659aa23
Type
Standard
Back to Health Canada Approvals